In a filing, Cg Oncology Inc revealed its Director POST LEONARD E unloaded Company’s shares for reported $30760.0 on Apr 28 ’25. In the deal valued at $30.76 per share,1,000 shares were sold. As a result of this transaction, POST LEONARD E now holds 0 shares worth roughly $0.0.
Then, POST LEONARD E sold 1,000 shares, generating $28,000 in total proceeds. Upon selling the shares at $28.00, the Director now owns 0 shares.
Before that, LEONARD E POST bought 4,000 shares. Cg Oncology Inc shares valued at $111,200 were divested by the Director at a price of $27.80 per share.
JP Morgan initiated its Cg Oncology Inc [CGON] rating to an Overweight in a research note published on May 02, 2025; the price target was $41. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in mid April with a ‘”a Sector perform”‘ rating. TD Cowen began covering CGON with “Buy” recommendation on January 07, 2025. UBS started covering the stock on October 24, 2024. It rated CGON as “a Buy”.
Price Performance Review of CGON
On Monday, Cg Oncology Inc [NASDAQ:CGON] saw its stock fall -2.24% to $24.86. Over the last five days, the stock has lost -1.19%. Cg Oncology Inc shares have fallen nearly -13.32% since the year began. Nevertheless, the stocks have fallen -11.25% over the past one year.
How much short interest is there in Cg Oncology Inc?
A steep rise in short interest was recorded in Cg Oncology Inc stocks on 2025-04-30, growing by 3.17 million shares to a total of 11.22 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-31 was 8.05 million shares. There was a rise of 28.28%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 23, 2024 when RBC Capital Mkts began covering the stock and recommended ‘”an Outperform”‘ rating along with a $66 price target.
